SLC19A1によるCDN、葉酸、抗葉酸の輸送メカニズムを解明(Scientists Unveil Complete Mechanism of SLC19A1 Transporting CDNs, Folates, and Antifolates)

ad

2025-04-09 中国科学院(CAS)

中国科学院生物物理研究所と北京理工大学の研究チームは、SLC19A1トランスポーターが葉酸、抗葉酸薬、環状ジヌクレオチド(CDN)をどのように輸送するかの完全な分子機構を解明した。抗体支援型スクリーニングで構造を安定化させ、高分解能構造解析を実施。葉酸と抗葉酸薬は単量体として結合し、CDNは異なる様式で同じポケットに結合することが判明。特定のアミノ酸残基の変異でCDN輸送のみが選択的に阻害され、基質特異的阻害剤設計への理論基盤となる。この研究は免疫療法や精密抗がん剤の開発に貢献する。

<関連情報>

SLC19A1を介した葉酸および環状ジヌクレオチド輸送の分子基盤 Molecular basis of SLC19A1-mediated folate and cyclic dinucleotide transport

Qixiang Zhang,Xuyuan Zhang,Kexin Liu,Yalan Zhu,Xiaohua Nie,Junxiao Ma,Panpan Sun,Zhaolong Li,Yina Gao,Songqing Liu,Ang Gao,Liguo Zhang & Pu Gao
Nature Communications  Published:02 April 2025
DOI:https://doi.org/10.1038/s41467-025-58378-1

SLC19A1によるCDN、葉酸、抗葉酸の輸送メカニズムを解明(Scientists Unveil Complete Mechanism of SLC19A1 Transporting CDNs, Folates, and Antifolates)

Abstract

The solute carrier protein SLC19A1 is crucial for transporting folate nutrients, antifolate chemotherapeutics, and more recently cyclic dinucleotides (CDNs) immune transmitters, influencing various physiological and pathological processes. While the inward-open state of human SLC19A1 (hSLC19A1) has been previously described, key aspects regarding its conformational dynamics, substrate selectivity, and precise mechanisms underlying CDNs transport remain elusive. Using an antibody-facilitated conformation screening strategy, we present cryo-electron microscopy structures of hSLC19A1 in its outward-open state with and without bound substrates, revealing detailed mechanisms of substrate recognition and conformational changes during transport. We identify both general and specific features for folate/antifolate recognition, including an SLC19A1-specific pocket for accommodating γ-carboxylate-modified antifolates. Intriguingly, CDNs bind as monomers within the canonical pocket of outward-open hSLC19A1, contrasting with dimeric binding in inward-open structures. Together with functional assays, these findings provide a framework for developing antifolate drugs and CDN-targeted therapies, advancing our understanding of SLC19A1’s physiological and therapeutic functions.

生物工学一般
ad
ad
Follow
ad
タイトルとURLをコピーしました